Efficacy of Hybrid Vitamin D Receptor Agonist/Histone Deacetylase Inhibitors in Vitamin D-Resistant Triple-Negative 4T1 Breast Cancer.

Bijian Krikor,Kaldre Dainis,Wang Tian-Tian,Bouttier Manuella,Boucher Annie,Alaoui-Jamali Moulay,White John H,Gleason James L

The Journal of steroid biochemistry and molecular biology（2018）

引用 10|浏览6

暂无评分

摘要

•Bifunctional hybrids containing vitamin D receptor agonist and histone deactylase inhibitor activity are described.•Hybrids are highly antiproliferative against vitamin D-resistant, triple-negative 4T1 breast cancer cells in vitro and in vivo.•Hybrids are efficacious at reducing 4T1 lung metastases.

查看译文

关键词

Vitamin D,Histone deacetylase inhibitors,Hybrid molecules,Breast cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要